Vital Farms Weighs Take-Private Bid After 80% Decline
Vital Farms shares surged 8.3% as reports emerged that the company is exploring strategic alternatives, including a potential sale, amid a steep drop in market value from its peak.
Vital Farms (NASDAQ:VITL) shares rose 8.3% on September 17, 2026, following reports that the pasture-raised egg producer is evaluating strategic options, including a take-private transaction. According to a report cited by GN stocks/nasdaq, the company is considering an acquisition with a targeted valuation range of $15 to $25 per share. This news emerged after the stock’s market capitalization fell more than 80% from a high of approximately $2.3 billion to around $430 million, or about $10 per share.
The move in Vital Farms' stock reflects market reaction to the potential premium offered in a buyout scenario. StoneX analyst Ben Klieve maintained a Buy rating and an $18 price target, noting that the proposed valuation range exceeds the current trading price. The company’s current share price of $11.08 is 76% below its 52-week high of $46.17, recorded in September 2025.
Recent Earnings Missed Expectations
Vital Farms’ fourth-quarter results showed mixed performance, with revenue growing 28.7% year-over-year to $213.6 million, meeting analyst estimates. However, earnings per share came in at $0.35, falling 11% short of consensus. The company’s full-year 2026 guidance also disappointed investors, with a revenue midpoint of $910 million, which was 3.1% below the consensus estimate.
Profitability concerns were highlighted by the company’s adjusted EBITDA guidance of $110 million, significantly lower than Wall Street’s average estimate of $133.7 million. This gap raised questions about the company’s ability to maintain growth while managing costs, contributing to the stock’s 62.8% decline since the start of the year.
Stock Volatility Remains High
Vital Farms has experienced significant price swings, with 36 moves greater than 5% over the past year. The largest recent drop occurred seven months ago, when the stock fell 18.9% on weak forward guidance. Investors who held $1,000 worth of shares five years ago now see a value of only $619.34, reflecting the company’s challenging trajectory despite recent operational growth.
